These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32670598)

  • 21. "Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose.
    Aquizerate A; Rousselet M; Cochard A; Guerlais M; Gerardin M; Lefebvre E; Duval M; Laforgue EJ; Victorri-Vigneau C
    Harm Reduct J; 2024 Jan; 21(1):20. PubMed ID: 38263159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
    Tse WC; Djordjevic F; Borja V; Picco L; Lam T; Olsen A; Larney S; Dietze P; Nielsen S
    Int J Drug Policy; 2022 Feb; 100():103513. PubMed ID: 34798434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Take -home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death- a pilot study.
    Papp J; Vallabhaneni M; Morales A; Schrock JW
    BMC Health Serv Res; 2019 Dec; 19(1):957. PubMed ID: 31829228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do heroin overdose patients require observation after receiving naloxone?
    Willman MW; Liss DB; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating the total utilization of take home naloxone during an unregulated drug toxicity crisis: A Bayesian modeling approach.
    Irvine MA; Bardwell S; Williams S; Liu L; Ge W; Kinniburgh B; Coombs D; Buxton JA
    Int J Drug Policy; 2024 Jun; 128():104454. PubMed ID: 38788389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rethinking 'carriage' of take-home naloxone.
    McDonald R; Parkin S; Eide D; Neale J; Clausen T; Metrebian N; Carter B; Strang J
    Int J Drug Policy; 2021 Sep; 95():103253. PubMed ID: 33848942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
    Holmén E; Hammarberg A; Kåberg M; Storbjörk J
    Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
    Williams AV; Marsden J; Strang J
    Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of opioid overdose interventions delivered within emergency departments.
    Chen Y; Wang Y; Nielsen S; Kuhn L; Lam T
    Drug Alcohol Depend; 2020 Aug; 213():108009. PubMed ID: 32580113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA.
    Hurt BR; Hussain A; Aledhaim A; Moayedi S; Schenkel SM; Kim HK
    Subst Use Misuse; 2020; 55(13):2237-2242. PubMed ID: 32729772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "It can save your life, that's all I know," barriers and facilitators for engagement in take-home naloxone for people receiving opioid substitution treatment in regional Australia: An explorative study.
    Natale I; Harvey C; Wood P; Anderson K
    Qual Res Med Healthc; 2023 Jul; 7(2):10868. PubMed ID: 37692452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injection Drug Use Frequency Before and After Take-Home Naloxone Training.
    Colledge-Frisby S; Rathnayake K; Nielsen S; Stoove M; Maher L; Agius PA; Higgs P; Dietze P
    JAMA Netw Open; 2023 Aug; 6(8):e2327319. PubMed ID: 37540514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
    Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
    PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
    Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
    Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More than saving lives: Qualitative findings of the UNODC/WHO Stop Overdose Safely (S-O-S) project.
    Walker S; Dietze P; Poznyak V; Campello G; Kashino W; Dzhonbekov D; Kiriazova T; Nikitin D; Terlikbayeva A; Nevendorff L; Busse A; Krupchanka D
    Int J Drug Policy; 2022 Feb; 100():103482. PubMed ID: 35042142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage.
    Burton G; McAuley A; Schofield J; Yeung A; Matheson C; Parkes T
    Int J Drug Policy; 2021 Oct; 96():103298. PubMed ID: 34078563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Take-home naloxone: a building block of drug emergency prophylaxis in Germany].
    Fleißner S; Stöver H; Schäffer D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Sep; 66(9):1035-1041. PubMed ID: 37233811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "You've got to care to carry this stuff" Community implications from take-home naloxone use: A qualitative study.
    Kano M; Salvador JG; Katzman W; Sussman AL; Takeda MY
    J Subst Abuse Treat; 2020 Aug; 115():108030. PubMed ID: 32600618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial.
    Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL
    Trials; 2020 Nov; 21(1):976. PubMed ID: 33243291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.